Gut dysbiosis in cystic fibrosis

Slides:



Advertisements
Similar presentations
Long-term non-invasive ventilation in cystic fibrosis — Experience over two decades William G. Flight, Jonathan Shaw, Susan Johnson, A. Kevin Webb, Andrew.
Advertisements

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Ian D. Molyneux, Tanya Moon, A. Kevin Webb, Alyn H. Morice 
The prevalence of “risky behaviour” in adults with cystic fibrosis
Treatment compliance in children and adults with Cystic Fibrosis
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Cystic fibrosis research in allied health and nursing professions
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Amoxicillin–clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings  Gwen Duytschaever, Geert Huys,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
David N. Sheppard  Journal of Cystic Fibrosis 
The ease of breathing test tracks clinical changes in cystic fibrosis
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population  Brandie D. Wagner, Frank J. Accurso,
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis  Donna Drury, Vijay Laxmi Grey, Guylaine Ferland, Caren Gundberg,
Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat  Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,
A.H. Gifford  Journal of Cystic Fibrosis 
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes  Adrienne P. Borschuk, Robin S. Everhart, Michelle.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
A new method of sweat testing: the CF Quantum®sweat test
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage  Luke J. Berry, Barbara Sheil, Luke Garratt,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Gut dysbiosis in cystic fibrosis Pauline D. Scanlan, Angus Buckling, Weidong Kong, Yvette Wild, Susan V. Lynch, Freya Harrison  Journal of Cystic Fibrosis  Volume 11, Issue 5, Pages 454-455 (September 2012) DOI: 10.1016/j.jcf.2012.03.007 Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 In three of four participant pairs, the microbial community isolated from the individual with CF showed lower species richness, evenness and diversity than that isolated from the healthy control individual. Evenness measures the relative distribution of community members and diversity is a metric that takes both richness and evenness into account. Journal of Cystic Fibrosis 2012 11, 454-455DOI: (10.1016/j.jcf.2012.03.007) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions